Volume 16, Number 4—April 2010
Research
Livestock-associated Methicillin-Resistant Staphylococcus aureus Sequence Type 398 in Humans, Canada
George R. Golding, Louis Bryden, Paul N. Levett, Ryan R. McDonald, Alice Wong, John Wylie, Morag R. Graham, Shaun Tyler, Gary Van Domselaar, Andrew E. Simor, Denise Gravel, and Michael R. Mulvey
Table 2
Antimicrobial drug susceptibility of the clinical isolates of methicillin-resistant Staphylococcus aureus sequence type 398, Canada, 2008*
| Drug | Susceptibility, μg/mL |
|||||
|---|---|---|---|---|---|---|
| 07 BA 06477 | 08 BA 02176 | 08 BA 08100 | 08 BA 13895 | 08 BA 22334 | T40929 | |
| Clindamycin | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 |
| Vancomycin | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Erythromycin | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| SXT | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 |
| Synercid | 0.5 | 1 | <0.25 | <0.25 | <0.25 | <0.25 |
| Nitrofurantoin | <32 | <32 | <32 | <32 | <32 | <32 |
| Tetracycline | >16 | >16 | >16 | ≤2 | >16 | >16 |
| Ciprofloxacin | 0.5 | 0.25 | 0.5 | 0.25 | 0.5 | 0.5 |
| Rifampin | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 | <0.25 |
| Fusidic acid | 0.25 | 0.12 | 0.25 | 0.12 | 0.12 | 0.12 |
| Linezolid | 2 | 2 | 2 | 1 | 0.5 | 0.5 |
| Gentamicin | 1 | 1 | 1 | 1 | ≤0.5 | 1 |
| Mupirocin | 0.5 | 0.25 | <0.12 | <0.12 | 0.25 | <0.12 |
*SXT, sulfamethoxazole/trimethoprim.
